Investigation of DNA Integration into Reproductive Organs Following Intramuscular Injection of DNA in Mice

Publish Year: 1391
نوع سند: مقاله ژورنالی
زبان: English
View: 192

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RBMB-1-1_004

تاریخ نمایه سازی: 10 شهریور 1400

Abstract:

Background: DNA immunization with plasmid DNA encoding bacterial, viral, parasitic, and tumor antigens has been reported to trigger protective immunity. The use of plasmid DNA vaccinations against many diseases has produced promising results in animal and human clinical trials; however, safety concerns about the use of DNA vaccines exist, such as the possibility of integration into the host genome, and elicitation of adverse immune responses. Methods: In this study, we examined the potential integration and bio-distribution of pcDNA۳.۱+PA, a new vaccine candidate with GenBank accession # EF۵۵۰۲۰۸, encoding the PA۶۳ gene, in reproductive organs of mice; ovaries and uterus in female, and testis in male. Animals of both sexes were injected intramuscularly with pcDNA۳.۱+PA. Host genome integration and tissue distribution were examined using PCR and RT-PCR two times monthly for six months. Results: RT-PCR confirmed that pcDNA۳.۱+PA was not integrated into the host genome and did not enter reproductive organs. Conclusions: This finding has important implications for the use of pcDNA۳.۱+PA plasmid as a vaccine and opens new perspectives in the DNA vaccine area.

Authors

Fatemeh Vahedi

Razi Vaccine & Serum Research Institute, Mashhad, Iran

Najmeh Nazari

Biochemistry Department, Payam-e-Noor University, Mashhad, Iran

Shirin Arbabi

Biochemistry Department, Payam-e-Noor University, Mashhad, Iran

Yasser Peymanfar

Razi Vaccine & Serum Research Institute, Mashhad, Iran